A benzothiophene-carboxamide is a potent inhibitor of IL-1β induced VCAM-1 gene expression in human endothelial cells
- 18 March 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 382 (3) , 323-326
- https://doi.org/10.1016/0014-5793(96)00202-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.Molecular and Cellular Biology, 1993
- Functional analysis of the human vascular cell adhesion molecule 1 promoter.The Journal of Experimental Medicine, 1992
- Isolation of a rel -related Human cDNAThat Potentially Encodes the 65-kD Subunit of NF-κBScience, 1991
- Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsalCell, 1990
- The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene productCell, 1990
- VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding siteCell, 1990
- Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytesCell, 1989
- NF-κB: A pleiotropic mediator of inducible and tissue-specific gene controlCell, 1989
- IκB: a Specific Inhibitor of the NF-κB Transcription FactorScience, 1988